Norepinephrine-mediated regulation of 5HT1 receptor functioning in human platelets

Neurochemical Research

Volumn 33, Issue 7, 2008, Pages 1292-1300

  Trincavelli, M L ^a   Cuboni, S ^a   Montali, M ^a   Santaguida, S ^a   Lucacchini, A ^a   Martini, C ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

5HT1 receptors; Adrenergic receptors; Human platelets; Norepinephrine; Receptor desensitisation

Indexed keywords

ADENYLATE CYCLASE; NORADRENALIN; PROTEIN KINASE C; SEROTONIN 1 RECEPTOR;

ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; DRUG RECEPTOR BINDING; HUMAN; IMMUNOPRECIPITATION; NEUROTRANSMISSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; THROMBOCYTE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENYLATE CYCLASE; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; BLOOD PLATELETS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DATA INTERPRETATION, STATISTICAL; ENZYME INHIBITORS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; KINETICS; NOREPINEPHRINE; PHENTOLAMINE; PHOSPHORYLATION; PROPRANOLOL; PROTEIN KINASE C; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, SEROTONIN, 5-HT1;

EID: 44549086374     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9582-8     Document Type: Article

References (52)

1. Blier P (2001) Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response. J Psych Neurosci 26:3-10
2. Mongeau R, de Montigny C, Blier P (1994) Electrophysiologic evidence for desensitization of alpha 2-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration. Neuropsychopharmacol 10:41-51
3. Yoshioka M, Matsumoto M, Numazawa R et al (1995) Changes in the regulation of 5-hydroxytryptamine release by alpha2-adrenoceptors in the rat hippocampus after long-term desipramine treatment. Eur J Pharmacol 294:565-570
4. Szabo ST, Blier P (2001) Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus. Neuropsychopharmacol 25:845-857
5. Bandoh T, Hayashi M, Ino K et al (2004) Acute effect of milnacipran on the relationship between the locus coeruleus noradrenergic and dorsal raphe serotonergic neuronal transmitters. Eur Neuropsychopharmacol 14:471-478
6. Werry TD, Wilkinson GF, Willars GB (2003) Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+. Biochem J 374:281-296
7. Freedman NJ, Lefkowitz RJ (1996) Desensitization of G protein-coupled receptors. Recent Progress Hormon Res 51:319-351
8. Bohm SK, Grady EF, Bunnet NW (1997) Regulatory mechanisms that modulate signaling by G protein coupled receptors. Biochem J 322:1-18
9. Bunemann M, Hosey MM (1999) G-protein coupled receptor kinases as modulators of G protein signalling. J Physiol 517:5-23
10. Luttrell LM, Lefkowitz RJ (2002) The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 115:455-465
11. Chuang TT, Iacovelli L, Sallese M et al (1996) G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications. Trends Pharmacol Sci 17:416-421
12. Popoli M, Mori S, Brunello N et al (2001) Serine/threonine kinases as molecular targets of antidepressants: implications for pharmacological treatment and pathophysiology of affective disorders. Pharmacol Ther 89:149-170
13. Wieland S, Lucki I (1990) Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test. Psychopharmacol 101:497-504
14. Lesch KP, Wiesmann M, Hoh A et al (1992) 5-HT1A receptor-effector system responsiveness in panic disorder. Psychopharmacol 106:111-117
15. Van den Hove DL, Lauder JM, Scheepens A et al (2006) Prenatal stress in the rat alters 5-HT1A receptor binding in the ventral hippocampus. Brain Res 1090:29-34
16. Kalynchuk LE, Pinel JP, Meaney MJ (2006) Serotonin receptor binding and mRNA expression in the hippocampus of fearful amygdala-kindled rats. Neurosci Lett 396:38-43
17. Broocks A, Bandelow B, George A et al (2000) Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder. Int Clin Psychopharmacol 15:153-161
18. Dell'Osso L, Carmassi C, Palego L et al (2004) Serotonin-mediated cyclic AMP inhibitory pathway in platelets of patients affected by panic disorder. Neuropsychobiol 50:28-36
19. Martini C, Trincavelli ML, Tuscano D et al (2004) Serotonin-mediated phosphorylation of extracellular regulated kinases in platelets of patients with panic disorder versus controls. Neurochem Int 44:627-639
20. Braune S, Albus M, Frohler M et al (1994) Psychophysiological and biochemical changes in patients with panic attacks in a defined situational arousal. Eur Arch Psych Clin Neurosci 244:86-92
21. Bremner JD, Krystal JH, Southwick SM et al (1996) Noradrenergic mechanisms in stress and anxiety: II, clinical studies. Synapse 23:39-51
22. Sullivan GM, Oquendo MA, Huang YY et al (2006) Elevated cerebrospinal fluid 5-hydroxyindoleacetic acid levels in women with comorbid depression and panic disorder. Int J Neuropsychopharmacol 9:547-556
23. Pejchal T, Foley MA, Kosofsky BE et al (2002) Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography. Br J Pharmacol 135:1115-1122
24. Bouali S, Evrard A, Chastanet M et al (2003) Sex hormone-dependent desensitization of 5-HT1A autoreceptors in knockout mice deficient in the 5-HT transporter. Eur J Neurosci 18:2203-2212
25. Bradbury MJ, Giracello DR, Chapman DF et al (2003) Metabotropic glutamate receptor 5 antagonist-induced stimulation of hypothalamic-pituitary-adrenal axis activity: interaction with serotonergic systems. Neuropharmacol 44:562-572
26. Hensler JG (2003) Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life Sci 72:1665-1682
27. El Mansari M, Blier P (2005) Responsiveness of 5-HT(1A) and 5-HT2 receptors in the rat orbitofrontal cortex after long-term serotonin reuptake inhibition. J Psych Neurosci 30:268-274
28. Werkman TR, Glennon JC, Wadman WJ et al (2006) Dopamine receptor pharmacology: interactions with serotonin receptors and significance for the aetiology and treatment of schizophrenia. CNS Neurol Disord Drug Targets 5:3-23
29. Aharonovitz O, Granot Y (1996) Stimulation of mitogen-activated protein kinase and Na+/H+ exchanger in human platelets. J Biol Chem 271:16494-16499
30. Stahl SM (1977) The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch Gen Psych 34:509-516
31. Owens MJ, Nemeroff CB (1994) Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 40:288-295
32. Barkan T, Peled A, Modai I et al (2006) Serotonin transporter characteristics in lymphocytes and platelets of male aggressive schizophrenia patients compared to non-aggressive schizophrenia patients. Eur Neuropsychopharmacol 16:572-579
33. Lauterbach E, Brunner J, Hawellek B et al (2006) Platelet 5-HT2A receptor binding and tryptophan availability in depression are not associated with recent history of suicide attempts but with personality traits characteristic for suicidal behavior. J Affect Disord 91:57-62
34. Nakanishi S, Kakita S, Takahashi I et al (1992) Wortmannin, a microbial product inhibitor of myosin light chain kinase. J Biol Chem 267:2157-2163
35. Penn RB, Parent JL, Pronin AN et al (1999) Pharmacological inhibition of protein kinases in intact cells: antagonism of beta adrenergic receptor ligand binding by H-89 reveals limitations of usefulness. J Pharmacol Exp Ther 288:428-437
36. Davies SP, Reddy H, Caivano M et al (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105
37. Brodde OE, Hardung A, Ebel H et al (1982) GTP regulates binding of agonists to alpha 2-adrenergic receptors in human platelets. Arch Int Pharm Ther 258:193-207
38. Zawilska JB, Zalewska-Kaszubska J, Marczak G et al (2000) Characterization of beta-adrenergic receptors in duck cerebral cortex. Acta Neurobiol Exp 60:301-307
39. Gessi S, Campi F, Varani K et al (1999) Alpha2-adrenergic agonist modulation of [35S]GTP gammaS binding to guanine-nucleotide-binding-proteins in human platelet membranes. Life Sci 64:1403-1413
40. Freitag CM, Domschke K, Rothe C et al (2006) Interaction of serotonergic and noradrenergic gene variants in panic disorder. Psychiatr Genet 16:59-65
41. Maron E, Shlik J (2006) Serotonin function in panic disorder: important, but why? Neuropsychopharmacol 31:1-11
42. Mongeau R, Weiss M, de Montigny C et al (1998) Effect of acute, short- and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons. Neuropharmacol 37:905-918
43. Butler J, O'Halloran A, Leonard BE (1992) The Galway Study of Panic Disorder II: changes in some peripheral markers of noradrenergic and serotonergic function in DSM III-R panic disorder. J Affect Disorders 26:89-99
44. Varrault A, Bockaert J, Waeber C (1992) Activation of 5-HT1A receptors expressed in NIH-3T3 cells induces focus formation and potentiates EGF effect on DNA synthesis. Mol Biol Cell 3:961-969
45. Banerjee P, Berry-Kravis E, Bonafede-Chhabra D, et al (1993) Heterologous expression of the serotonin 5-HT1A receptor in neural and non-neural cell lines. Biochem Biophys Res Comm 192:104-110
46. Liu YF, Albert PR (1991) Cell-specific signaling of the 5-HT1A receptor. Modulation by protein kinases C and A. J Biol Chem 266:23689-23697
47. Popoli M, Brunello N, Perez J et al (2000) Second messenger-regulated protein kinases in the brain: their functional role and the action of antidepressant drugs. J Neurochem 74:21-33
48. Raymond JR (1991) Protein kinase C induces phosphorylation and desensitization of the human 5-HT1A receptor. J Biol Chem 266:14747-14753
49. Raymond JR, Olsen CL (1994) Protein kinase A induces phosphorylation of the human 5-HT1A receptor and augments its desensitization by protein kinase C in CHO-K1 cells. Biochem 33:11264-11269
50. Lembo PM, Albert PR (1995) Multiple phosphorylation sites are required for pathway-selective uncoupling of the 5-hydroxytryptamine1A receptor by protein kinase C. Mol Pharmacol 48:1024-1029
51. Lembo PM, Ghahremani MH, Morris SJ et al (1997) A conserved threonine residue in the second intracellular loop of the 5-hydroxytryptamine 1A receptor directs signaling specificity. Mol Pharmacol 52:164-171
52. Raymond JR, Mukhin YV, Gettys TW et al (1999) The recombinant 5-HT1A receptor: G protein coupling and signalling pathways. Br J Pharmacol 127:1751-1764